WallStreetZenWallStreetZen

NASDAQ: XXII
22nd Century Group Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their XXII stock forecasts and price targets.

Forecast return on equity

Is XXII forecast to generate an efficient return?

Forecast return on assets

Is XXII forecast to generate an efficient return on assets?

XXII revenue forecast

What is XXII's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$33.5M+4.12%
Avg 2 year Forecast
$34.5M+7.22%
XXII's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

XXII revenue growth forecast

How is XXII forecast to perform vs Tobacco companies and vs the US market?
Company
4.12%
Industry
-2.41%
Market
13.2%
XXII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
XXII's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

XXII vs Tobacco Stocks

TickerPricePrice TargetUp/downsideConsensus
XXII$1.62N/AN/A
HPCO$1.00N/AN/A
GNLN$0.63N/AN/A
KAVL$3.73N/AN/A
ISPR$5.54N/AN/A

22nd Century Group Stock Forecast FAQ

What is XXII's revenue growth forecast for 2024-2025?

(NASDAQ: XXII) 22nd Century Group's forecast annual revenue growth rate of 4.12% is forecast to beat the US Tobacco industry's average forecast revenue growth rate of -2.41%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.2%.

22nd Century Group's revenue in 2024 is $32,204,000.On average, 1 Wall Street analysts forecast XXII's revenue for 2024 to be $116,773,355, with the lowest XXII revenue forecast at $116,773,355, and the highest XXII revenue forecast at $116,773,355.

In 2025, XXII is forecast to generate $120,256,008 in revenue, with the lowest revenue forecast at $120,256,008 and the highest revenue forecast at $120,256,008.

If you're new to stock investing, here's how to buy 22nd Century Group stock.

What is XXII's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: XXII) forecast ROA is N/A, which is lower than the forecast US Tobacco industry average of 16.04%.

What is XXII's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: XXII) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.